Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

Ann‐Lii Cheng, Chih‐Hung Hsu, Jen‐Kou Lin, +18

PubMed

Urinary Bladder CancerChemopreventive AgentOncologyChemoprevention StrategyOncogenic Agent +13

Phase I Clinical Trial of Oral Curcumin

Ricky A. Sharma, Stephanie A. Euden, Sharon L. Platton, +10

Clinical Cancer Research

Biotransformation of Curcumin Through Reduction and Glucuronidation in Mice

Min‐Hsiung Pan, Tsang‐Miao Huang, Jen‐Kun Lin

Drug Metabolism and Disposition

Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate.

Mou‐Tuan Huang, Robert C. Smart, Ching-Quo Wong, +1

PubMed

Chemoprevention StrategyDermatologyTumor BiologyMedicinal ChemistryOncology +14

Potential anticancer activity of turmeric (Curcuma longa)

Ramadasan Kuttan, P Bhanumathy, K. Nirmala, +1

Cancer Letters

Medicinal ChemistryChemoprevention StrategyMedicineHerbal MedicinePotential Anticancer Activity +3

Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound.

Chinthalapally V. Rao, Abraham Rivenson, Barbara Simi, +1

PubMed

InflammationColon CarcinogenesisChemoprevention StrategyDietary CurcuminMedicine +12

Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC–MS/MS

Kuo-Yi Yang, Lei-Chwen Lin, Ting-Yu Tseng, +2

Journal of Chromatography B

Oral BioavailabilityMedicineHerbal MedicineHerbal AnalysisPhytopharmacology +3

Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice.

Mou‐Tuan Huang, You-Rong Lou, Wei Ma, +3

PubMed

Inhibitory EffectsOncologyColon CarcinogenesisDietary CurcuminCommercial Grade Curcumin +12

Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration

Giuseppe Garcea, Donald J. L. Jones, Rajinder Singh, +6

British Journal of Cancer

Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents

Brian K. Adams, Eva Ferstl, Matthew C. Davis, +10

Bioorganic & Medicinal Chemistry

Medicinal ChemistryMedicineAnti-angiogenesis AgentsBiological EvaluationAnti-cancer Agent +5